// App-Quantinova.ai

679 : Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Partow Kebriaei

Principal Investigators

  • Mei-Jie Zhang

  • Stefan O. Ciurea

  • Hillard M. Lazarus

  • Robert Peter Gale

  • Mark Litzow

  • Christopher N. Bredeson

  • Matthew D. Seftel

  • Michael A Pulsipher

  • Jaap Jan Boelens

  • Joseph Alvarnas

  • Richard E. Champlin

  • Hai-Lin Wang

  • Stephen J. Forman

  • Vinod Pullarkat

  • Daniel Weisdorf

  • David I. Marks

  • Ibrahim Aldoss

  • Marcos de Lima

  • H. Jean Khoury

  • Brenda M. Sandmaier

  • Mary M. Horowitz

  • Andrew Artz

  • Nelli Bejanyan

Medical Centers

  • Division of Hematology, University of Washington School of Medicine and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH

  • Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

  • University of Minnesota, Minneapolis, MN

  • City of Hope National Medical Center, Duarte, CA

  • Hematology, City of Hope Medical Center, Duarte, CA

  • The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Section of Hematology/Oncology, University of Chicago, Chicago, IL

  • CASE Comprehensive Cancer Center, University Hospital of Cleveland Medical Center, Cleveland, OH

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Mayo Clinic, Rochester, MN

  • Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

  • Department of Medical Oncology/Hematology, CancerCare Manitoba, Winnipeg, MB, Canada

  • Adult Bone Marrow Transplant, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

  • Division of Hematology, Oncology, and Blood and Marrow Transplantation, Childrens Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, CA

  • Division of Biostatistics, Institution for Health and Society, Medical College of Wisconsin, Milwaukee, WI

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, United States,

  • Pediatric Blood and Bone Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands

  • Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA

  • Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom

  • Department of Hematology and Hematopoietic Cell Transplantation, and Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

Locations

  • United States

  • Canada

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Hematocrit

Drug/Treatment

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved